Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03925662

Mebendazole as Adjuvant Treatment for Colon Cancer

Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Sherief Abd-Elsalam · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

mebendazole treating colon cancer

Detailed description

mebendazole as adjuvant treatment for colon cancer

Conditions

Interventions

TypeNameDescription
DRUGFolfox with avastinFolfox with avastin only
DRUGMebendazoleFolfox with avastin with mebendazole

Timeline

Start date
2019-04-01
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2019-04-24
Last updated
2019-04-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03925662. Inclusion in this directory is not an endorsement.